308 related articles for article (PubMed ID: 35639372)
21. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
[TBL] [Abstract][Full Text] [Related]
22. Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex.
Bickeböller H; Campion D; Brice A; Amouyel P; Hannequin D; Didierjean O; Penet C; Martin C; Pérez-Tur J; Michon A; Dubois B; Ledoze F; Thomas-Anterion C; Pasquier F; Puel M; Demonet JF; Moreaud O; Babron MC; Meulien D; Guez D; Chartier-Harlin MC; Frebourg T; Agid Y; Martinez M; Clerget-Darpoux F
Am J Hum Genet; 1997 Feb; 60(2):439-46. PubMed ID: 9012418
[TBL] [Abstract][Full Text] [Related]
23. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease.
Tiraboschi P; Hansen LA; Masliah E; Alford M; Thal LJ; Corey-Bloom J
Neurology; 2004 Jun; 62(11):1977-83. PubMed ID: 15184600
[TBL] [Abstract][Full Text] [Related]
24. A locus at 19q13.31 significantly reduces the ApoE ε4 risk for Alzheimer's Disease in African Ancestry.
Rajabli F; Beecham GW; Hendrie HC; Baiyewu O; Ogunniyi A; Gao S; Kushch NA; Lipkin-Vasquez M; Hamilton-Nelson KL; Young JI; Dykxhoorn DM; Nuytemans K; Kunkle BW; Wang L; Jin F; Liu X; Feliciano-Astacio BE; ; Schellenberg GD; Dalgard CL; Griswold AJ; Byrd GS; Reitz C; Cuccaro ML; Haines JL; Pericak-Vance MA; Vance JM
PLoS Genet; 2022 Jul; 18(7):e1009977. PubMed ID: 35788729
[TBL] [Abstract][Full Text] [Related]
25. Association between apolipoprotein E genotype and Alzheimer disease in African American subjects.
Graff-Radford NR; Green RC; Go RC; Hutton ML; Edeki T; Bachman D; Adamson JL; Griffith P; Willis FB; Williams M; Hipps Y; Haines JL; Cupples LA; Farrer LA
Arch Neurol; 2002 Apr; 59(4):594-600. PubMed ID: 11939894
[TBL] [Abstract][Full Text] [Related]
26. Additive effect of LRP8/APOER2 R952Q variant to APOE epsilon2/epsilon3/epsilon4 genotype in modulating apolipoprotein E concentration and the risk of myocardial infarction: a case-control study.
Martinelli N; Olivieri O; Shen GQ; Trabetti E; Pizzolo F; Busti F; Friso S; Bassi A; Li L; Hu Y; Pignatti PF; Corrocher R; Wang QK; Girelli D
BMC Med Genet; 2009 May; 10():41. PubMed ID: 19439088
[TBL] [Abstract][Full Text] [Related]
27. The SIRT2 polymorphism rs10410544 and risk of Alzheimer's disease in two Caucasian case-control cohorts.
Polito L; Kehoe PG; Davin A; Benussi L; Ghidoni R; Binetti G; Quadri P; Lucca U; Tettamanti M; Clerici F; Bagnoli S; Galimberti D; Nacmias B; Sorbi S; Guaita A; Scarpini E; Mariani C; Forloni G; Albani D
Alzheimers Dement; 2013 Jul; 9(4):392-9. PubMed ID: 22651940
[TBL] [Abstract][Full Text] [Related]
28. ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer's disease.
Medway CW; Abdul-Hay S; Mims T; Ma L; Bisceglio G; Zou F; Pankratz S; Sando SB; Aasly JO; Barcikowska M; Siuda J; Wszolek ZK; Ross OA; Carrasquillo M; Dickson DW; Graff-Radford N; Petersen RC; Ertekin-Taner N; Morgan K; Bu G; Younkin SG
Mol Neurodegener; 2014 Mar; 9():11. PubMed ID: 24607147
[TBL] [Abstract][Full Text] [Related]
29. Transcriptomic Downregulation of APOE, Polymorphic Variations of APOE, Diet, Social Isolation, and Co-morbidities as Contributing Factors to Alzheimer's Disease: a Case-Control Study of Kashmiri Population.
Nissar K; Firdous P; Hussain A; Bashir S; Ahmad Z; Ganai BA
Mol Neurobiol; 2023 Oct; 60(10):5891-5901. PubMed ID: 37357229
[TBL] [Abstract][Full Text] [Related]
30. Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study.
Myers RH; Schaefer EJ; Wilson PW; D'Agostino R; Ordovas JM; Espino A; Au R; White RF; Knoefel JE; Cobb JL; McNulty KA; Beiser A; Wolf PA
Neurology; 1996 Mar; 46(3):673-7. PubMed ID: 8618665
[TBL] [Abstract][Full Text] [Related]
31. Apolipoprotein E genotypes associated with Alzheimer disease and concomitant stroke.
Fekih-Mrissa N; Klai S; Mrad M; Mansour M; Zaouali J; Gritli N; Mrissa R
J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):681-5. PubMed ID: 23871727
[TBL] [Abstract][Full Text] [Related]
32. [ACT/AA polymorphism could duplicate the APOE*epsilon4-associated Alzheimer's disease risk].
Hernández-Charro B; Moreno S; Valiente A; Manubens JM; Villar MD; Ramos-Arroyo MA
Med Clin (Barc); 2004 Sep; 123(7):251-4. PubMed ID: 15482730
[TBL] [Abstract][Full Text] [Related]
33. Risk of Alzheimer disease with the epsilon4 allele for apolipoprotein E in a population-based study of men aged 62-73 years.
Breitner JC; Jarvik GP; Plassman BL; Saunders AM; Welsh KA
Alzheimer Dis Assoc Disord; 1998 Mar; 12(1):40-4. PubMed ID: 9539409
[TBL] [Abstract][Full Text] [Related]
34. The epsilon2 and epsilon4 alleles of the apolipoprotein gene are associated with age-related macular degeneration.
Baird PN; Guida E; Chu DT; Vu HT; Guymer RH
Invest Ophthalmol Vis Sci; 2004 May; 45(5):1311-5. PubMed ID: 15111582
[TBL] [Abstract][Full Text] [Related]
35. Dissecting the role of Amerindian genetic ancestry and the ApoE ε4 allele on Alzheimer disease in an admixed Peruvian population.
Marca-Ysabel MV; Rajabli F; Cornejo-Olivas M; Whitehead PG; Hofmann NK; Illanes Manrique MZ; Veliz Otani DM; Milla Neyra AK; Castro Suarez S; Meza Vega M; Adams LD; Mena PR; Rosario I; Cuccaro ML; Vance JM; Beecham GW; Custodio N; Montesinos R; Mazzetti Soler PE; Pericak-Vance MA
Neurobiol Aging; 2021 May; 101():298.e11-298.e15. PubMed ID: 33541779
[TBL] [Abstract][Full Text] [Related]
36. Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome.
Bejanin A; Iulita MF; Vilaplana E; Carmona-Iragui M; Benejam B; Videla L; Barroeta I; Fernandez S; Altuna M; Pegueroles J; Montal V; Valldeneu S; Giménez S; González-Ortiz S; Muñoz L; Padilla C; Aranha MR; Estellés T; Illán-Gala I; Belbin O; Camacho V; Wilson LR; Annus T; Osorio RS; Videla S; Lehmann S; Holland AJ; Zetterberg H; Blennow K; Alcolea D; Clarimon J; Zaman SH; Blesa R; Lleó A; Fortea J
JAMA Neurol; 2021 Aug; 78(8):937-947. PubMed ID: 34228042
[TBL] [Abstract][Full Text] [Related]
37. Updated meta-analysis of the role of APOE ε2/ε3/ε4 alleles in frontotemporal lobar degeneration.
Su WH; Shi ZH; Liu SL; Wang XD; Liu S; Ji Y
Oncotarget; 2017 Jul; 8(27):43721-43732. PubMed ID: 28487499
[TBL] [Abstract][Full Text] [Related]
38. The effect of APOE and other common genetic variants on the onset of Alzheimer's disease and dementia: a community-based cohort study.
van der Lee SJ; Wolters FJ; Ikram MK; Hofman A; Ikram MA; Amin N; van Duijn CM
Lancet Neurol; 2018 May; 17(5):434-444. PubMed ID: 29555425
[TBL] [Abstract][Full Text] [Related]
39. Association of apolipoprotein E genotype and Alzheimer disease in African Americans.
Murrell JR; Price B; Lane KA; Baiyewu O; Gureje O; Ogunniyi A; Unverzagt FW; Smith-Gamble V; Gao S; Hendrie HC; Hall KS
Arch Neurol; 2006 Mar; 63(3):431-4. PubMed ID: 16533971
[TBL] [Abstract][Full Text] [Related]
40. Association of APOE epsilon2/epsilon3/epsilon4 and promoter gene variants with dementia but not cardiovascular mortality in old age.
Heijmans BT; Slagboom PE; Gussekloo J; Droog S; Lagaay AM; Kluft C; Knook DL; Westendorp RG
Am J Med Genet; 2002 Jan; 107(3):201-8. PubMed ID: 11807900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
